Literature DB >> 8451420

Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation.

M L Whiteman1, M J Post, J R Berger, L G Tate, M D Bell, L P Limonte.   

Abstract

The authors investigated the spectrum of radiologic findings in a large series (n = 47) of patients seropositive to human immunodeficiency virus (HIV) 1 and with pathologically proved progressive multifocal leukoencephalopathy, to determine the characteristic imaging pattern of the disease. Thirty-six computed tomographic (CT) scans and 29 magnetic resonance (MR) imaging studies obtained in the 47 patients were retrospectively reviewed and correlated with pathologic and clinical findings. Contrast agents were used in 32 CT procedures and 13 MR imaging studies. Lesions typically were hypoattenuating on CT scans and were characterized by areas of increased signal intensity without mass effect on dual-echo MR images. Lesions most often involved periventricular and subcortical white matter in parietooccipital or frontal lobes. Fifteen patients had posterior fossa lesions, and disease was limited to the posterior fossa in two. Lesions were also in the corpus callosum (seven patients), thalamus (eight patients), and basal ganglia (seven patients). In comparison with CT, MR imaging demonstrated greater sensitivity for the extent and number of lesions.

Entities:  

Mesh:

Year:  1993        PMID: 8451420     DOI: 10.1148/radiology.187.1.8451420

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  64 in total

Review 1.  Epidemiological evidence and molecular basis of interactions between HIV and JC virus.

Authors:  J R Berger; A Chauhan; D Galey; A Nath
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 2.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

3.  Progressive Multifocal Leukoencephalopathy.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-07       Impact factor: 3.598

4.  Progressive multifocal leukoencephalopathy with peripheral demyelinating neuropathy in a liver transplant patient.

Authors:  Smruti R Mohanty; Giuliano Testa; Douglas R Labrecque; Frank A Mitros
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-01

Review 5.  Progressive multifocal leukoencephalopathy and newer biological agents.

Authors:  Joseph R Berger
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

6.  Progressive multifocal leukoencephalopathy mimicking milliary CNS tuberculosis.

Authors:  Iñigo Corral; Carmen Quereda; Fernando Dronda; Enrique Navas; José Manuel Hermida; Carmen Moreno; Juan Martínez-San-Millán
Journal:  J Neurovirol       Date:  2015-08-05       Impact factor: 2.643

Review 7.  Progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

Review 8.  Progressive multifocal leukoencephalopathy (PML) associated with HIV Clade C--is not uncommon.

Authors:  M Netravathi; Anita Mahadevan; Parthasarathy Satishchandra; N Shobha; Pooja Mailankody; Thennarasu Kandavel; Saini Jitender; G Anantaram; S Nagarathna; S Govekar; B V Ravikumar; V Ravi; S K Shankar
Journal:  J Neurovirol       Date:  2013-05-23       Impact factor: 2.643

Review 9.  The role of polyomaviruses in human disease.

Authors:  Mengxi Jiang; Johanna R Abend; Silas F Johnson; Michael J Imperiale
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

Review 10.  Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature.

Authors:  Hiroki Yokoyama; Takashi Watanabe; Dai Maruyama; Sung-Won Kim; Yukio Kobayashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2008-10-15       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.